Fagron Compounding Services LLC dba Fagron Sterile Services recalls Neostigmine Methylsulfate Injection Solution, 3 mg per 3 mL, 1 mg per mL, 3 mL prefilled syringe, 5 syringes per package
Recalled July 11, 2018 · FDA recall D-0911-2018 · Fagron Compounding Services LLC
Hazard
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL. · FDA Class I
Units
390 prefilled syringes
Sold at
Nationwide in the USA
Description
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
Product
Neostigmine Methylsulfate Injection Solution, 3 mg per 3 mL, 1 mg per mL, 3 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile Services, ICB Laboratories, 8710 E 34th St. N., Wichita, KS 67205, NDC 71266-2003-01.
Manufacturer(s)
Fagron Compounding Services LLC dba Fagron Sterile Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →